| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/25/2003 | CA1341422C Retinoic acid receptor composition and method |
| 02/25/2003 | CA1341421C Preparation of enzymes having altered activity |
| 02/24/2003 | CA2426408A1 Method of protecting personal information |
| 02/21/2003 | WO2002016610A1 Novel protease gene |
| 02/21/2003 | WO2002014523A2 Methods for stable transformation of plants |
| 02/21/2003 | CA2420275A1 Novel protease gene |
| 02/20/2003 | WO2003014745A2 Method for identifying anti-inflammatory drugs |
| 02/20/2003 | WO2003014734A1 Method of detecting interaction between substance and protein, method of screening protein interacting with substance, and method of forming complex of substance and protein interacting with the substance |
| 02/20/2003 | WO2003014731A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 02/20/2003 | WO2003014728A1 Remedies for hepatitis c |
| 02/20/2003 | WO2003014704A2 Rapid and specific detection of campylobacter |
| 02/20/2003 | WO2003014703A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/20/2003 | WO2003014702A2 Uses of mammalian cytokine; related reagents |
| 02/20/2003 | WO2003014696A2 Methods of identifying functional analogs of peptide regulators of biological pathways |
| 02/20/2003 | WO2003014401A1 Methods for the identification of inhibitors of ferredoxin nadp oxidoreductase expression or activity in plants |
| 02/20/2003 | WO2003014393A1 METHOD OF DETECTING, IDENTIFYING AND COUNTING ENTERITIS VIBRIO USING GENE (rpoD) SEQUENCES ENCODING RNA POLYMERASE σ70 FACTOR |
| 02/20/2003 | WO2003014391A2 Method for the detection of a polymorphism in cpb2 |
| 02/20/2003 | WO2003014388A2 Method and nucleic acids for the analysis of colon cancer |
| 02/20/2003 | WO2003014386A2 Method for identifying macrocyclic polyketides |
| 02/20/2003 | WO2003014383A2 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 02/20/2003 | WO2003014381A1 System for detecting protease |
| 02/20/2003 | WO2003014380A2 Microoroganisms and cells for diagnosis and therapy of tumors |
| 02/20/2003 | WO2003014377A2 Competitive binding assay for identifying inhibitors of hcv polymerase |
| 02/20/2003 | WO2003014376A2 Sugar and lipid metabolism regulators in plants iii |
| 02/20/2003 | WO2003014373A2 Metal-binding proteins |
| 02/20/2003 | WO2003014372A2 Phytochelatin synthase |
| 02/20/2003 | WO2003014369A1 Nucleic acid ligands with intramolecular duplexes |
| 02/20/2003 | WO2003014368A2 Use of xylene monooxygenase for the oxidation of substituted monocyclic aromatic compounds |
| 02/20/2003 | WO2003014367A1 Method for purification of viral vectors having proteins which bind sialic acid |
| 02/20/2003 | WO2003014366A2 Rna amplification system using plant components in animal cells |
| 02/20/2003 | WO2003014365A2 Plant glycogenin homologs and use thereof in starch modification |
| 02/20/2003 | WO2003014364A1 Method for influencing the acceptance of minerals in transgenic plants |
| 02/20/2003 | WO2003014363A1 Vector for site-specific integration of heterologous dna sequences into the rdn a sites of methylotrophic yeasts |
| 02/20/2003 | WO2003014362A2 Method for producing a marker-free mutated target organism and plasmid vectors suitable for the same |
| 02/20/2003 | WO2003014361A1 Novel recombinant gene expression method by stop codon suppression |
| 02/20/2003 | WO2003014360A1 SURFACE EXPRESSION VECTORS HAVING pgsBCA, THE GENE CODING POLY-GAMMA-GLUTAMATE SYNTHETASE, AND A METHOD FOR EXPRESSION OF TARGET PROTEIN AT THE SURFACE OF MICROORGANISM USING THE VECTOR |
| 02/20/2003 | WO2003014359A2 A fusion protein |
| 02/20/2003 | WO2003014357A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | WO2003014356A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | WO2003014355A1 Nitrilase gene |
| 02/20/2003 | WO2003014353A2 Genetic products of ashbya gossypii, associated with transmembrane transport |
| 02/20/2003 | WO2003014352A2 Nucleic acids for aminocoumarin biosynthesis |
| 02/20/2003 | WO2003014351A2 Stress-associated genetic products from ashbya gossypii |
| 02/20/2003 | WO2003014350A1 Novel rice gene regulating salt stress tolerance |
| 02/20/2003 | WO2003014349A1 Bifactorial endosperm box, trans-activating factor that binds thereto, and method of regulation of promoter activity |
| 02/20/2003 | WO2003014348A1 Dna molecules from maize and methods of use thereof |
| 02/20/2003 | WO2003014347A2 Plant seed specific promoters |
| 02/20/2003 | WO2003014346A2 High-throughput dna-isolation and transfection for analysing the function of genes or genetic products |
| 02/20/2003 | WO2003014342A2 Identification of a dna variant associated with adult type hypolactasia |
| 02/20/2003 | WO2003014341A2 Chimeric proteins comprising a haem domain of a mammalian or plant cytochrome p450 and a scaffold-reductase domain from p450 bm3 of bacillus megaterium and uses thereof |
| 02/20/2003 | WO2003014338A1 Process for producing inactivated virus envelope |
| 02/20/2003 | WO2003014327A2 Stress-related polynucleotides and polypeptides in plants |
| 02/20/2003 | WO2003014325A2 Protein design automation for protein libraries |
| 02/20/2003 | WO2003014323A2 Human smooth muscle myosin heavy chain |
| 02/20/2003 | WO2003014322A2 Proteins associated with cell growth, differentiation, and death |
| 02/20/2003 | WO2003014318A2 Methods for treating diabetes and other blood sugar disorders |
| 02/20/2003 | WO2003014312A2 Alteration of acyltransferase domain substrate specificity |
| 02/20/2003 | WO2003014311A2 Methods for altering polyketide synthase genes |
| 02/20/2003 | WO2003014310A2 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof |
| 02/20/2003 | WO2003014309A2 Interleukin-1 receptors in the treatment of diseases |
| 02/20/2003 | WO2003014307A2 Antisense modulation of apolipoprotein(a) expression |
| 02/20/2003 | WO2003014306A2 Antisense modulation of cholesteryl ester transfer protein expression |
| 02/20/2003 | WO2003014301A2 Hprp4s as modifiers of the p53 pathway and methods of use |
| 02/20/2003 | WO2003014300A2 TRPS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 02/20/2003 | WO2003014299A2 SPHKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 02/20/2003 | WO2003014297A2 Compositions and methods relating to the daptomycin biosynthetic gene cluster |
| 02/20/2003 | WO2003014294A2 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | WO2003014163A1 Anti-idiotypic antibodies of hla class i molecules and the use thereof in the preparation of compositions that are designed to inhibit vascular activation |
| 02/20/2003 | WO2003014162A1 ANTIBODY RECOGNIZING GM1 GANGLIOSIDE-BOUND AMYLOID β-PROTEIN AND DNA ENCODING THE ANTIBODY |
| 02/20/2003 | WO2003014161A2 Antigen binding domains from fish |
| 02/20/2003 | WO2003014153A2 Cellular virus receptors and methods of use. |
| 02/20/2003 | WO2003014151A2 Human secreted proteins, their encoding polynucleotides, and uses thereof |
| 02/20/2003 | WO2003014150A2 Fusion proteins for insect control |
| 02/20/2003 | WO2003014149A2 Genetically modified cyclic-nucleotide controlled ion channels and the use thereof |
| 02/20/2003 | WO2003014148A2 Human fatty acid-coa ligase |
| 02/20/2003 | WO2003014145A2 Peptides that bind to atherosclerotic lesions |
| 02/20/2003 | WO2003014142A2 Phosphorylated histone h2b as an apoptosis marker |
| 02/20/2003 | WO2003014140A1 Compositions, methods and products comprising human papillomavirus for detecting and treating a cancer |
| 02/20/2003 | WO2003014077A2 Crystal forms and mutants of rank ligand |
| 02/20/2003 | WO2003013647A2 Electrodes coated with treating agent and uses thereof |
| 02/20/2003 | WO2003013615A1 Electroporative delivery of molecules to organs |
| 02/20/2003 | WO2003013599A2 Anti-coronavirus vaccine |
| 02/20/2003 | WO2003013598A2 Novel vaccine compositions and methods of vaccine preparation for veterinary and human diseases |
| 02/20/2003 | WO2003013597A1 Sub-unit vaccine for infectious pancreatic necrosis virus |
| 02/20/2003 | WO2003013593A2 Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder |
| 02/20/2003 | WO2003013590A1 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 02/20/2003 | WO2003013576A1 Regulation of the apj receptor for use in the treatment or prophylaxis of cardiac diseases |
| 02/20/2003 | WO2003013575A1 Modulation of leukocyte-endothelial interactions following ischemia |
| 02/20/2003 | WO2003013555A1 Method for amplifying expression from a cell specific promoter |
| 02/20/2003 | WO2003013537A2 Irinotecan for treatment of cancer |
| 02/20/2003 | WO2003013536A2 Methods for treatment of cancer using irinotecan based on ugt1a1 |
| 02/20/2003 | WO2003013535A2 Use of irinotecan for improved treatment of cancer based on mdr1 |
| 02/20/2003 | WO2003013534A2 Methods for the treatment of cancer with irinotecan based on cyp3a5 |
| 02/20/2003 | WO2003013533A2 Methods for improved treatment of cancer with irinotecan based on mrp1 |
| 02/20/2003 | WO2003013437A2 Compositions and methods for the prevention and treatment of huntington's disease |
| 02/20/2003 | WO2003013431A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/20/2003 | WO2003013426A2 Multivalent synthetic vaccine for cancer |
| 02/20/2003 | WO2003013423A2 Antithrombotic agent |
| 02/20/2003 | WO2003013422A2 Methods for the treatment and prognosis of leukemia and other cancer types |
| 02/20/2003 | WO2003013234A2 Method for the in vivo screening of the biological activity of an acetylcholinesterase inhibitor compound on one or more cellular targets other than acetylcholinesterase |